Pediatric Protections Extended To Infant Formula, Dietary Ingredient Studies
This article was originally published in The Tan Sheet
HHS protections covering children involved in clinical trials are extended to studies of new dietary supplement ingredients and infant formulas, as well as research supporting petitions for nutrient content or health claims, under an FDA interim rule published in the Federal Register April 24.
You may also be interested in...
The "Children's Health Act of 2000" passed the House May 9 by a 419-2 vote under suspension of the rules. The bill (HR 4365) was introduced May 3 by Reps. Michael Bilirakis (R-Fla.) and Sherrod Brown (D-Ohio).
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning